Pharmaceutical
High-Resolution, and DSCSA-Compliant Printing Solutions
Pharmaceutical Traceability and Quality Control
Pharmaceutical manufacturing requires clear, sharp print quality. Smart-Jet® Thermal Ink Jet (TIJ) printers are perfect for pharmaceutical manufacturing applications because they deliver high-resolution, high speed, and cost-effective inline printing to ensure compliance with regulations like the Drug Supply Chain Security Act (DSCSA), by printing variable product identifiers, lot numbers, and bar codes/2D symbols on a wide variety of substrates, including coated chipboard, flexible packaging, foil, plastic, and glass. Smart-Jet® printers offers adaptability for non-porous and porous surfaces, require practically no maintenance, and delvier high accuracy for detailed information critical for traceability, quality control, and brand differentiation, making Smart-Jet® printers the perfect option for both large-scale production, as well as personalized medicine applications.
Key Benefits for Pharmaceutical Manufacturing
Regulatory Compliance: Smart-Jet® printers produce sharp, legible product identifiers, barcodes, and GS1 Datamatrix codes on each package, crucial for meeting serialization and track-and-trace requirements.
High-Resolution Printing: Smart-Jet® printers deliver high-resolution printing, which is essential for the accuracy and scannability of small, critical data like lot numbers, expiration/expiry dates, serial codes, and 2D symbols on packaging.
Print on a Wide Range of Substrates: Smart-Jet® printers effectively print on a wide range of pharmaceutical packaging, including both porous and non-porous substrates, ensuring broad applicability over a large range of production lines.
Cost-Effectiveness: With economical print cartridges and strongly reduced maintenance requirements, Smart-Jet® printers offer cost-effective technology for industrial printing, leading to lower operational costs and increased productivity and throughput. The speed and efficiency of Smart-Jet® printers allows for printing of unique information on every item, supporting high-throughput production environments common in pharmaceutical manufacturing.
Password Level Protection and Data Logging: The Smart-Jet® printer range features definable operator password-protected levels, so you can easily customize what operators can access. Additionally, Smart-Jet® printers generate activity logs, enabling you to comply with electronic records and signatures, such as the Code of Federal Regulations 21 CFR 11 requirements for recordkeeping.
Simple Communication Integration: Smart-Jet® printers feature a command protocol language called POD (Print On Demand). With this protocol, you can easily integrate Smart-Jet® printers with other equipment on your packaging line. This includes cameras and scales, for print and weight verification. You can also download and print information from a database
What is the Drug Supply Chain Security Act?
The DSCSA, or Drug Supply Chain Security Act, is a U.S. law that aims to create a federal traceability framework for prescription drugs, allowing for electronic tracking and tracing of products throughout the supply chain to improve security and patient safety. This involves unique product identifiers, requirements for authorized trading partners, and interoperable electronic exchange of transaction information to detect and prevent counterfeit, stolen, or otherwise harmful drugs from entering the supply chain.
Product Identification: Requires unique product identifiers on prescription drug packages, including a serial number, GTIN, lot number, and expiration date.
Authorized Trading Partners: Establishes standards regarding who can operate in the drug supply chain, including manufacturers, re-packagers and co-packagers, wholesale distributors, third-party logistics providers, and dispensers (pharmacies).
Electronic Tracing: Mandates the exchange of transaction information (TI), history (TH), and statements (TS) to track products from manufacturer to dispenser.
Verification: Trading partners can verify the authenticity of drug packages to ensure they are not compromised.
National Licensure: Requires wholesale distributors and third-party logistics providers to be licensed by the U.S. Food and Drug Administration (FDA).
For more information, visit: https://www.fda.gov/drugs/drug-supply-chain-integrity/drug-supply-chain-security-act-dscsa